Medicines in Clinical Practice
Shared care, remote prescribing, repeat prescribing and system interfaces
Applied learning on shared care, remote prescribing, repeat prescribing and system interfaces.
Learning objectives
• Prescribe safely when clinical information and responsibility are distributed across services. • Recognise when remote prescribing is inappropriate because assessment or examination is inadequate. • Use shared-care arrangements as explicit agreements rather than assumptions. • Design repeat prescribing around review, monitoring and current clinical need. • Manage interface risks at discharge, transfer, referral and handover.
Overview
Learning objectives
- Prescribe safely when clinical information and responsibility are distributed across services.
- Recognise when remote prescribing is inappropriate because assessment or examination is inadequate.
- Use shared-care arrangements as explicit agreements rather than assumptions.
- Design repeat prescribing around review, monitoring and current clinical need.
- Manage interface risks at discharge, transfer, referral and handover.
Interfaces create predictable risk
Many serious medicine problems arise not because one decision was obviously wrong, but because information or responsibility was lost between teams. Hospital discharge, outpatient initiation, community monitoring, care-home administration, private treatment and cross-border care can all create gaps. The safest approach is to make the current prescriber, monitoring plan, review point and communication route explicit.
Remote prescribing is a mode of care, not a lower standard
The GMC applies prescribing standards across face-to-face and remote care. Before prescribing remotely, the clinician should decide whether the mode of consultation allows an adequate assessment, whether relevant records and medicines information can be verified, whether two-way dialogue is possible, and whether examination or investigations are needed. Convenience does not justify prescribing with insufficient information.
Shared care must be accepted
Shared-care protocols can support continuity for medicines that cross specialist and generalist care, but they do not automatically transfer responsibility. Roles for prescribing, monitoring, review, dose adjustment and escalation should be clear, and the receiving clinician should be willing and competent to take on the agreed tasks. If the arrangement is not accepted, the initiating service retains responsibility until safe alternative arrangements are made.
Repeat prescribing is an active clinical process
A repeat system should not allow treatment to continue indefinitely without reassessing indication, benefit, harm and monitoring. The appropriate review interval depends on the medicine, condition and patient. Requests for medicines that have not been used for a long time, repeated early requests, overdue tests or recent hospital changes should prompt assessment rather than automatic reauthorisation.
Discharge and transfer
Medication changes at discharge should state what was started, stopped or changed, why, how long treatment is intended to continue, what monitoring is required and who is expected to act. Ambiguous phrases such as “GP to monitor” can be unsafe if no interval, parameter or action plan is supplied. Equally, a receiving clinician should clarify uncertainty rather than silently continuing a regimen they do not understand.
Private, NHS and cross-provider prescribing
When a patient receives care from more than one provider, each prescriber still needs sufficient information to prescribe safely. A request from another clinician is not a substitute for independent judgement. Medicines obtained privately, online or abroad may not appear in local records. Ask explicitly about other prescribers, over-the-counter medicines and non-medical sources when clinically relevant.
Sources for this module
Electronic systems help but do not reconcile reality
Electronic prescribing, shared records and clinical decision support improve safety, but no system is complete. Lists may be outdated, duplicated or omit recent changes. Clinicians should reconcile discrepancies rather than assuming that the most accessible list is correct. Patients and carers are often important sources of information, but their account should be integrated with other evidence rather than used as the sole source when risk is high.
Practical reasoning framework
At any interface ask: Who currently owns prescribing? Who owns monitoring? What changed and why? What information is missing? Has the receiving clinician accepted the task? When is review due? What happens if results are abnormal or the patient deteriorates? Has the patient been told who to contact?
Sources for this module
- GMC - Deciding if it is safe to prescribe; remote prescribing; shared care and repeat prescribing sections.
- NICE NG5 - Medicines optimisation, including medicines reconciliation and communication systems.
- AWTTC - All Wales guidance to support integrated medicines management in community settings (October 2025).
- Local shared-care protocols and current organisational prescribing policies.
Educational note: medicine-specific doses, thresholds, contraindications and rapidly changing regulatory requirements must be checked against current authoritative guidance and local policy at the point of care.
